| Entry |
|
|---|
| Name |
Triciribine phosphate (USAN) |
|---|
| Formula |
C13H17N6O7P
|
|---|
| Exact mass |
400.0896
|
|---|
| Mol weight |
400.28
|
|---|
| Structure |
|
|---|
| Class |
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01439 Arabinofuranosyl type antineoplastic
|
|---|
| Efficacy |
Antineoplastic, Antimetabolite, AKT serine/threonine kinase inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01439 Arabinofuranosyl type antineoplastic
D06221 Triciribine phosphate
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
AGC group
AKT (PKB)
D06221 Triciribine phosphate (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 27
1 C1y C 8.6800 -24.5700
2 C1y C 10.0800 -24.5700
3 C1y C 10.5000 -23.2400
4 O2x O 9.3800 -22.4700
5 C1y C 8.2600 -23.2400
6 N4y N 11.6900 -22.5400
7 C1b C 7.0700 -22.5400
8 O2b O 5.8100 -23.2400
9 O1a O 7.8400 -25.6900
10 O1a O 10.9200 -25.6900
11 N5x N 12.6000 -24.9200
12 C8x C 13.8600 -25.6200
13 N5x N 15.0500 -24.9200
14 C8y C 15.0500 -23.5200
15 C8y C 13.8600 -22.8200
16 C8y C 12.6000 -23.5200
17 N4y N 16.2400 -22.8200
18 N5x N 16.2400 -21.4200
19 C8y C 15.0500 -20.7200
20 C8y C 13.8600 -21.4200
21 C8x C 12.3900 -21.2100
22 C1a C 17.4553 -23.5151
23 N1a N 15.0500 -19.3200
24 P1b P 4.4100 -23.2400
25 O1c O 4.4100 -21.8400
26 O1c O 3.0100 -23.2400
27 O1c O 4.4100 -24.6400
BOND 30
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 3 6 1 #Up
7 5 7 1 #Up
8 7 8 1
9 1 9 1 #Down
10 2 10 1 #Down
11 11 12 2
12 12 13 1
13 13 14 2
14 14 15 1
15 15 16 2
16 11 16 1
17 14 17 1
18 17 18 1
19 18 19 2
20 19 20 1
21 15 20 1
22 20 21 2
23 21 6 1
24 16 6 1
25 17 22 1
26 19 23 1
27 8 24 1
28 24 25 2
29 24 26 1
30 24 27 1
|
|---|
